A Study of the effects of a test-food on sleep-improving

Not Applicable

• Conditions: Healthy male/female adults

• Registration Number: JPRN-UMIN000049060
• Lead Sponsor: CPCC Company Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-12-10
• Study Start: 2023-09-29
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

Subjects- (1) taking in sleep-affecting foods, not less than three times a week (2) who will take medicines which might affect the test (e.g., sleeping pill) during the test period (3) vaccinated within two weeks before this study, or planning to vaccinate during intaking of test-foods (4) with not less than 30.0 kg/m2 of BMI (5) with sleep-apnea syndrome (6) with previous medical history of sleep disorder (7) with a continuous medical treatment for sleep disorder (8) cannot use the sleep-scope during the test period (9) with an alcohol intake at the measurement of brain waves (10) with an overnight trip during the test period (11) with extremely irregular dietary habit/life rhythm (12) with a serious sleep-affecting rhinitis (13) with excessive alcohol intake (14) QIDS-J >=11 (15) with the roomer planning to participate in this study (16) restricting their mealtimes to no more than once a day (not less than once a week), within the last month (17) with medical history of serious diseases (18) with pregnancy, possibly one, or lactating (19) with drug/food allergy (wheat, egg, milk) (20) being fitted with a pacemaker (21) with sensitive skin, irritating by an adhesive tape (22) being under another clinical test (medicine or health food), or participated in that within the last 4 weeks, or will join that after the consent (23) who donated their blood components or blood (0.2 L) within the last month (24) who donated his blood (0.4 L) within the last 3 months (25) who donated her blood (0.4 L) within the last 4 months (26) being collected in total of his blood (1.2 L) within the last 12 months and in this study (27) being collected in total of her blood (0.8 L) within the last 12 months and in this study (28) being determined as ineligible for participation by the principal/sub investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified